Clinical Trial Of Doxorubicin Versus Trabectedin Plus Doxorubicin In The First Line Treatment Of Patients With Advanced Non Operable And/Or Metastatic Soft Tissue Sarcomas

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Grupo Espanol de Investigacion en Sarcomas.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Grupo Espanol de Investigacion en Sarcomas
ClinicalTrials.gov Identifier:
NCT01104298
First received: April 13, 2010
Last updated: April 27, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)